Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia

NCT01799993 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

725

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Bacterial

Interventions

DRUG: Amikacin Inhalation Solution (BAY41-6551)
DRUG: Aerosolized Placebo

Sponsor

Bayer

Collaborators

[object Object]